Abstract:Allergen specific immunotherapy (SIT) is believed the only causative treatment that could change the progress of asthma. The mechanisms of SIT are complex, including the very early desensitization effects, modulation of T and B cell responses and related antibody isotypes, and migration of eosinophils, basophils, and mast cells to tissues, as well as release of their mediators. Basic studies have shown that immunotherapy works mainly through expanding allergen-specific Th1 immunity and suppressing the Th2 responses resulting from clinical observation. Treg cells are considered play key roles in modulating the switch from Th2 cells to Th0 or Th1 cells, through cytokine IL-10 and TGF-β, as well as the switch from production of IgE to blocking antibody IgG4 isotype. The clinical practice over 100 years demonstrated its unique advantage over the first line medicine inhaled corticosteroid. It has dual functions including causative and preventative therapy. It can significantly reduce the symptom score and airway hyperresponsiveness in asthmatic patients. Furthermore, its salutary effects continue for years after the completion of treatment course. Based on the administration route, conventional subcutaneous specific immunotherapy (SCIT) and sublingual specific immunotherapy (SLIT) are the most popular methods used in clinical work. However, new administration methods such as intralymphatic immunotherapy and epicutaneous allergen- specific immunotherapy are under active clinical trials. The future studies of immunotherapy will focus on the alternative therapy with modified extract to provide the least side effects and the best clinical efficacies.Allergen specific immunotherapy (SIT), also called desensitization or hyposensitization, is the repeated administration of allergen vaccines to allergic individuals in order to provide long term relief of symptoms and improvement in quality of life during subsequent natural allergen exposure (Bousquet et al., 1998).Bronchial asthma is considered a type I allergic reaction characterized by Th2 cells domination and allergen specific IgE mediation. The immunotherapy targeting at the allergic reaction is the optimal treatment. Clinical trials showed though inhaled gluccocorticoid could control the symptoms of asthma, it could not block the inflammation of airway (Guilbert et al., 2006). However, SIT not only improves the clinical symptoms with reduced symptom score and medication, but also has long-term effect and prevents the progress of inflammation. Thus SIT is believed the only causative treatment that could change the progress of asthma. The current chapter focuses on the mechanism of SIT and its clinical practice.

An Advance in Recombination of Allergenic Proteins by Gene Manipulation

Generation of IgE-specific Cytotoxic T Lymphocytes As a Novel Immunotherapeutic Approach for the Treatment of Allergic Asthma.

New Therapeutics for Allergic Airway Diseases

Induction Of Cd4(+)Cd25(+)Foxp3(+)Il-10(+) T Cells In Hdm-Allergic Asthmatic Children With Or Without Sit

Multidisciplinary Approaches to Allergies

Adjuvant Allergen Fusion Proteins as Novel Tools for the Treatment of Type I Allergies

The Molecular Allergen Recognition Profile in China as Basis for Allergen-Specific Immunotherapy

Immunotherapy of Asthma: from Basic Research to Clinical Practices

Induction of Adaptive T Regulatory Cells That Suppress the Allergic Response by Coimmunization of DNA and Protein Vaccines.

Gene Editing in Allergic Diseases: Identification of Novel Pathways and Impact of Deleting Allergen Genes

Genetically modified immunomodulatory cell-based biomaterials in tissue regeneration and engineering

Molecular characterization of allergens and component-resolved diagnosis of IgE-mediated mango fruit allergy

Innovative delivery systems for epicutaneous immunotherapy

Allergen immunotherapy now and in the future

Impact of Preexisting Circulating Effector T cells on the Outcome of ABO-Incompatible Adult LDLT

Allergen-specific immunotherapy for allergic conjunctivitis

Allergen sensitization study in Dongying, China: An epidemiological study

[Methods of saturation analysis in endocrinology].

A Survey on Wi-Fi Protocols: WPA and WPA2

Mechanisms of allergen-specific immunotherapy

Physical therapy management of infants and children with hypophosphatasia.